Mitsubishi Pharma Corporation

ARGANOVA

PHARMACEUTICAL PREPARATIONS, NAMELY, ANTI-THROMBOTIC AGENT FOR THE PREVENTION AND TREATMENT OF THROMBOTIC DISEASES, HEPARIN-INDUCED THROMBOCYTOPENIA, HEMODIALYSIS, CARDIAC, CEREBRAL AND PERIPHERAL DISEASES, FOR HUMAN USE;

ARGANOVAS

PHARMACEUTICAL PREPARATIONS, NAMELY, ANTI-THROMBOTIC AGENT FOR THE PREVENTION AND TREATMENT OF THROMBOTIC DISEASES, HEPARIN-INDUCED THROMBOCYTOPENIA, HEMODIALYSIS, AND CARDIAC, CEREBRAL AND PERIPHERAL DISEASES FOR HUMAN USE;

ATECTEV

Pharmaceutical preparations for the treatment of cardiovascular system diseases, namely, heart diseases and blood diseases; pharmaceutical preparations for the treatment of central nervous system disorders, namely, stroke and dementia; pharmaceutical preparations for the treatment of ophthalmological disorders, namely, glaucoma; pharmaceutical preparations for the treatment of respiratory system diseases, namely, pulmonary diseases; pharmaceutical preparations for the treatment of renal diseases; pharmaceutical preparations for use in surgical procedures and organ transplantation to prevent reperfusion injury;

ERAPREVE

Pharmaceutical preparations for the treatment of cardiovascular system diseases, namely, heart diseases and blood diseases; pharmaceutical preparations for the treatment of central nervous system disorders, namely, stroke and dementia; pharmaceutical preparations for the treatment of ophthalmological disorders, namely, glaucoma; pharmaceutical preparations for the treatment of respiratory system diseases, namely, pulmonary diseases; pharmaceutical preparations for the treatment of renal diseases; pharmaceutical preparations for use in surgical procedures and organ transplantation to prevent reperfusion injury;

FENSERA

Pharmaceutical preparations for the treatment of cardiovascular system diseases, namely, heart diseases and blood diseases; pharmaceutical preparations for the treatment of central nervous system disorders, namely, stroke and dementia; pharmaceutical preparations for the treatment of ophthalmological disorders, namely, glaucoma; pharmaceutical preparations for the treatment of respiratory system diseases, namely, pulmonary diseases; pharmaceutical preparations for the treatment of renal diseases; pharmaceutical preparations for use in surgical procedures and organ transplantation to prevent reperfusion injury;

MOLESORTER

APPARATUS AND INSTRUMENTS FOR PHYSICS AND CHEMISTRY, NAMELY, COMPUTERS, IMAGE ANALYSIS COMPUTER PROGRAMS, EXTRACTORS AND MATERIAL HANDLERS, AND MASS SPECTROMETERS, ALL USED FOR CHEMICAL ANALYSIS, FOR ANALYZING PROTEINS AND FOR USE IN GENOMICS AND FUNCTIONAL GENOMICS, INCLUDING PROTEOMICS; MEASURING APPARATUS AND INSTRUMENTS; MACHINES AND APPARATUS FOR ELECTRONIC DISTRIBUTION AND CONTROL, NAMELY, ELECTRIC CONVERTERS FOR OUTLETS; ELECTRICAL AND MAGNETIC MEASURING INSTRUMENTS, NAMELY, ELECTRICAL TRANSFORMERS; PHOTOGRAPHIC APPARATUS AND INSTRUMENTS, NAMELY, PHOTOGRAPHIC CAMERAS AND PROJECTORS; MOTION PICTURE APPARATUS AND INSTRUMENTS, NAMELY, MOTION PICTURE CAMERAS; OPTICAL APPARATUS AND INSTRUMENTS, NAMELY, OPTICAL SCANNERS, DISCS, FILTERS, AND MIRRORS; ELECTRODES FOR MEASURING THE METABOLIC RATES TO PREDICT EFFICACY OF DRUGS; EXPOSED CAMERA FILMS; PHOTOGRAPHIC SLIDE TRANSPARENCIES; EXPOSED SLIDE MOUNTS; RECORDED VIDEO DISCS AND VIDEO TAPES FEATURING MUSIC; JOB RECORDING MACHINES; PHOTOGRAPHIC COPYING APPARATUS AND MACHINES; COMPUTERS; SCIENTIFIC APPARATUS AND INSTRUMENTS TO ANALYZE GENE EXPRESSION AND FUNCTION OF PROTEINS AND THEREOF DERIVED INFORMATION, IN PARTICULAR, MAGNETIC DATA CARRIERS, DATA PROCESSING EQUIPMENT AND COMPUTERS, FOR THE USE OF GENERATING DATABASES AND CONTAINING THE RESULTS OF GENE STRUCTURE, GENE FUNCTION AND GENE EXPRESSION ANALYSES AS WELL AS THEREOF DERIVED INFORMATION OF THE PROTEIN;MOLE SORTER;MEDICAL, SURGICAL, DENTAL AND VETERINARY INSTRUMENTS AND APPARATUS, NAMELY, BIOANALYTICAL APPLIANCES COMPRISING FLUIDIC INSTRUMENTS FOR SEPARATION AND AMASS SPECTROMETRIC TECHNOLOGIES; MEDICAL APPARATUS AND INSTRUMENTS FOR DIAGNOSTIC PURPOSES FOR DRUG DEVELOPMENT AND THE SCREENING AND THE EXPRESSION ANALYSIS FOR THE DETECTION OF GENETIC DISEASES AND DEFECTS; MEDICAL APPARATUS AND INSTRUMENTS FOR TREATING DISEASES BY GENE THERAPY; APPARATUS AND INSTRUMENTS FOR VETERINARY USE IN THE TREATMENT OF DISEASES IN PETS AND LIVESTOCK;

NULIPHOR

Pharmaceutical preparations for the treatment of and prevention of hyperphosphatemia, chronic kidney disease, hyperlipidemia, diabetes, metabolic syndrome, hypercholesterolemia, urological diseases and disorders, cardiovascular diseases, diseases of the central and peripheral nervous system, gastrointestinal disorders, allergy, obesity, secondary hyperparathyroidism and insulin resistance syndrome;

VATEZOR

Pharmaceutical preparations for the treatment and prevention of Alzheimer's disease, vascular dementia, mild cognitive impairment, attention deficit hyperactive disorder, autism, glaucoma, and associated disorder of depression, parkinsonism and neurosis;

VIVOCTEN

Pharmaceutical preparations for the treatment and prevention of Alzheimer's disease, vascular dementia, mild cognitive impairment, attention deficit hyperactive disorder, autism, glaucoma, and associated disorder of depression, parkinsonism and neurosis;

ZAXARD

Pharmaceutical preparations for the treatment and prevention of Alzheimer's disease, vascular dementia, mild cognitive impairment, attention deficit hyperactive disorder, autism, glaucoma, and associated disorder of depression, parkinsonism and neurosis;